Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chin Shern Lau

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Journal of Infectious Diseases|October 13, 2021
Frequent Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Testing in a Disease-Free PopulationChin Shern Lau, Tar Choon Aw
Vaccines|January 21, 2023
Considerations in Understanding Vaccine EffectivenessChin Shern Lau, Tar Choon Aw
Antibodies (Basel, Switzerland)|December 23, 2021
Disease Prevalence Matters: Challenge for SARS-CoV-2 TestingChin-Shern Lau, Tar-Choon Aw
Diagnostics (Basel, Switzerland)|May 28, 2022
SARS-CoV-2 Antigen Testing Intervals: Twice or Thrice a Week?Chin Shern Lau, Tar-Choon Aw
Annals of the Academy of Medicine, Singapore|January 19, 2021
Screening for Congenital HypothyroidismChin Shern Lau, Roy Joseph, Tar Choon Aw
Vaccines|January 24, 2025
Reflections on COVID-19: A Literature Review of SARS-CoV-2 TestingChin Shern Lau, Helen M L Oh, Tar Choon Aw
The Journal of Applied Laboratory Medicine|October 17, 2020
Faster HbA1c Turnaround Times Using a Dedicated Analyzer Based on Turbidimetric Inhibition Immunoassay TechnologyChin Shern Lau, Melva Lim, See Ping Hoo, et al.
Vaccines|February 26, 2022
Evaluation and Validation of the Roche Elecsys SARS-CoV-2 Antigen Electro-Chemiluminescent Immunoassay in a Southeast Asian RegionChin Shern Lau, Soon Kieng Phua, See Ping Hoo, et al.
Diagnostics (Basel, Switzerland)|October 16, 2025
99th-Percentile Upper Reference Limit for the New Snibe High-Sensitivity Troponin I Assay in a Southeast Asian PopulationYun Zhang, Chin Shern Lau, Ke Yang, et al.
Vaccines|February 26, 2022
SARS-CoV-2 Spike and Neutralizing Antibody Kinetics 90 Days after Three Doses of BNT162b2 mRNA COVID-19 Vaccine in SingaporeChin Shern Lau, Soon Kieng Phua, Ya Li Liang, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Journal of Infectious Diseases|October 13, 2021
Frequent Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Testing in a Disease-Free PopulationChin Shern Lau, Tar Choon Aw
Vaccines|January 21, 2023
Considerations in Understanding Vaccine EffectivenessChin Shern Lau, Tar Choon Aw
Antibodies (Basel, Switzerland)|December 23, 2021
Disease Prevalence Matters: Challenge for SARS-CoV-2 TestingChin-Shern Lau, Tar-Choon Aw
Diagnostics (Basel, Switzerland)|May 28, 2022
SARS-CoV-2 Antigen Testing Intervals: Twice or Thrice a Week?Chin Shern Lau, Tar-Choon Aw
Annals of the Academy of Medicine, Singapore|January 19, 2021
Screening for Congenital HypothyroidismChin Shern Lau, Roy Joseph, Tar Choon Aw
Vaccines|January 24, 2025
Reflections on COVID-19: A Literature Review of SARS-CoV-2 TestingChin Shern Lau, Helen M L Oh, Tar Choon Aw
The Journal of Applied Laboratory Medicine|October 17, 2020
Faster HbA1c Turnaround Times Using a Dedicated Analyzer Based on Turbidimetric Inhibition Immunoassay TechnologyChin Shern Lau, Melva Lim, See Ping Hoo, et al.
Vaccines|February 26, 2022
Evaluation and Validation of the Roche Elecsys SARS-CoV-2 Antigen Electro-Chemiluminescent Immunoassay in a Southeast Asian RegionChin Shern Lau, Soon Kieng Phua, See Ping Hoo, et al.
Diagnostics (Basel, Switzerland)|October 16, 2025
99th-Percentile Upper Reference Limit for the New Snibe High-Sensitivity Troponin I Assay in a Southeast Asian PopulationYun Zhang, Chin Shern Lau, Ke Yang, et al.
Vaccines|February 26, 2022
SARS-CoV-2 Spike and Neutralizing Antibody Kinetics 90 Days after Three Doses of BNT162b2 mRNA COVID-19 Vaccine in SingaporeChin Shern Lau, Soon Kieng Phua, Ya Li Liang, et al.
Pageof 2